Reduced chromatin acetylation of malignant salivary gland tumors correlates with enhanced proliferation.

about

Reduced chromatin acetylation of malignant salivary gland tumors correlates with enhanced proliferation.

Item

http://www.wikidata.org/entity/Q48276258

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Reduced chromatin acetylation ...... s with enhanced proliferation.

@en

Reduced chromatin acetylation ...... s with enhanced proliferation.

@nl

type

Item

label

Reduced chromatin acetylation ...... s with enhanced proliferation.

@en

Reduced chromatin acetylation ...... s with enhanced proliferation.

@nl

prefLabel

Reduced chromatin acetylation ...... s with enhanced proliferation.

@en

Reduced chromatin acetylation ...... s with enhanced proliferation.

@nl

P1476

Reduced chromatin acetylation ...... s with enhanced proliferation.

@en

P2093

Artur Cunha Vasconcelos

http://www.w3.org/2001/XMLSchema#string

Luise Meurer

http://www.w3.org/2001/XMLSchema#string

Manoela Domingues Martins

http://www.w3.org/2001/XMLSchema#string

Vivian Petersen Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

The language of covalent histone modifications

DNA methyltransferase Dnmt1 associates with histone deacetylase activity

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

Histone deacetylases and cancer

Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo

DNMT1 maintains progenitor function in self-renewing somatic tissue.

Pediatric head and neck tumors: an intra-demographic analysis using the SEER* database

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

P304

792-797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOP.12557

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pablo Agustin Vargas

F P Fonseca

Douglas Magno Guimarães

Rogerio M Castilho

Cristiane H Squarize

P577

2017-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28161900

http://www.w3.org/2001/XMLSchema#string